These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4957405)

  • 1. [Synergic activity of lysozyme in combination with antituberculous agents. I. Inhibitory activity against M. tuberculosis in vitro and synergic effect in vivo measured by S.S.A.A.T. method].
    Tsukiori N; Sasaki S; Takahashi T; Fukuda A
    Kekkaku; 1965 Dec; 40(12):555-9. PubMed ID: 4957405
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies in vitro on the antituberculous activities of 27753 (R.P), a semisynthetic derivative of griselimycine. II. Antituberculous activities of R.P. in combination with other antituberculous agents].
    Shibata A
    Bull Chest Dis Res Inst Kyoto Univ; 1984 Mar; 17(1-2):32-7. PubMed ID: 6442173
    [No Abstract]   [Full Text] [Related]  

  • 3. Iron enhances the antituberculous activity of pyrazinamide.
    Somoskovi A; Wade MM; Sun Z; Zhang Y
    J Antimicrob Chemother; 2004 Feb; 53(2):192-6. PubMed ID: 14729751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of 7-methyljuglone in combination with antituberculous drugs against Mycobacterium tuberculosis.
    Bapela NB; Lall N; Fourie PB; Franzblau SG; Van Rensburg CE
    Phytomedicine; 2006 Nov; 13(9-10):630-5. PubMed ID: 16987644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of weak acids, UV and proton motive force inhibitors on pyrazinamide activity against Mycobacterium tuberculosis in vitro.
    Wade MM; Zhang Y
    J Antimicrob Chemother; 2006 Nov; 58(5):936-41. PubMed ID: 16950824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and ex vivo activity of thioridazine derivatives against Mycobacterium tuberculosis.
    Martins M; Schelz Z; Martins A; Molnar J; Hajös G; Riedl Z; Viveiros M; Yalcin I; Aki-Sener E; Amaral L
    Int J Antimicrob Agents; 2007 Mar; 29(3):338-40. PubMed ID: 17239569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental study on the antituberculous activity of ofloxacins].
    Duan L; Liang G; Li H
    Zhonghua Jie He He Hu Xi Za Zhi; 1997 Apr; 20(2):98-100. PubMed ID: 10072834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of in vitro synergy when three antimicrobial agents are combined against Mycobacterium tuberculosis.
    Bhusal Y; Shiohira CM; Yamane N
    Int J Antimicrob Agents; 2005 Oct; 26(4):292-7. PubMed ID: 16150578
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria.
    Sohn H; Lee KS; Ko YK; Ryu JW; Woo JC; Koo DW; Shin SJ; Ahn SJ; Shin AR; Song CH; Jo EK; Park JK; Kim HJ
    Int J Antimicrob Agents; 2008 Jun; 31(6):567-71. PubMed ID: 18337064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on antituberculous activity of lividomycin in vitro].
    Horai Z; Shimizu K; Yamamoto K; Fujisawa Y; Yamashita K
    Kekkaku; 1971 Oct; 46(10):401-4. PubMed ID: 5004573
    [No Abstract]   [Full Text] [Related]  

  • 11. Antimycobacterial constituents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide.
    Mossa JS; El-Feraly FS; Muhammad I
    Phytother Res; 2004 Nov; 18(11):934-7. PubMed ID: 15597311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro antimycobacterial activity of a new quinolone, T-3761].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1995 Feb; 70(2):97-101. PubMed ID: 7699982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal inhibitory concentrations of lomefloxacin and minocycline against drug-sensitive and drug-resistant isolates of M. tuberculosis compared on L-J and 7H11 media.
    Kamala T; Herbert D; Venkatesan P; Paramasivan CN
    Int J Lepr Other Mycobact Dis; 1997 Sep; 65(3):375-8. PubMed ID: 9401493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea.
    Sriram D; Yogeeswari P; Madhu K
    Bioorg Med Chem Lett; 2006 Feb; 16(4):876-8. PubMed ID: 16303302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages.
    Khan A; Sarkar S; Sarkar D
    Int J Antimicrob Agents; 2008 Jul; 32(1):40-5. PubMed ID: 18538548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The study of the in vitro antituberculous activity of capreomycin].
    Ravagnan L; Renzini G
    Antibiotica; 1968 Sep; 6(3):152-61. PubMed ID: 4983488
    [No Abstract]   [Full Text] [Related]  

  • 17. Synthesis of new S-derivatives of clubbed triazolyl thiazole as anti-Mycobacterium tuberculosis agents.
    Shiradkar MR; Murahari KK; Gangadasu HR; Suresh T; Kalyan CA; Panchal D; Kaur R; Burange P; Ghogare J; Mokale V; Raut M
    Bioorg Med Chem; 2007 Jun; 15(12):3997-4008. PubMed ID: 17442576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of antitubercular agents of the 2d series: ethionamide, ethoxyd cycloserine and pyrazinamide on the development of drug resistance of Mycobacterium tuberculosis to tubazide and phthivazide].
    Makeeva OO
    Farmakol Toksikol; 1969; 32(2):202-5. PubMed ID: 4977183
    [No Abstract]   [Full Text] [Related]  

  • 19. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis.
    De Logu A; Palchykovska LH; Kostina VH; Sanna A; Meleddu R; Chisu L; Alexeeva IV; Shved AD
    Int J Antimicrob Agents; 2009 Mar; 33(3):223-9. PubMed ID: 19070992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The "in vitro" activity of rifampicin compared with ethambutol, capreomycin and isoniazid.
    Steinbrück PW
    Acta Tuberc Pneumol Belg; 1969; 60(3):413-6. PubMed ID: 4984421
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.